Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 7,866,474

« Back to Dashboard
Patent 7,866,474 protects PRADAXA and is included in one NDA. There have been two Paragraph IV challenges on Pradaxa.

This patent has twenty-one patent family members in seventeen countries.

Summary for Patent: 7,866,474

Title:Film container
Abstract: A film container (FIG. 4) comprises two rectangular films (5) joined together at their periphery to form a receiving chamber (6) for a filling (7), particularly a pharmaceutical formulation of an active substance, at least one of said films (5) being provided, for the purpose of tearing it open, with a marking (13) formed within the connecting region, which is exposed after the films (5) have been bent. The marking (13) extends centrally between two opposing outer edges (11) of the film container (1).
Inventor(s): Geser; Johannes (Ingelheim, DE), Beyer; Sebastian (Eltville, DE)
Assignee: Boehringer Ingelheim International GmbH (Ingelheim, DE)
Application Number:11/305,365
Patent Claim Types:
see list of patent claims
Formulation; Composition;
Patent Metrics:
Source: PatentQuant.com
Field: Handling
Back Citations: 77th percentile
Forward Citations: 1st percentile

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Boehringer Ingelheim
dabigatran etexilate mesylate
CAPSULE;ORAL022512-001Oct 19, 2010RXNo7,866,474Aug 31, 2027Y
Boehringer Ingelheim
dabigatran etexilate mesylate
CAPSULE;ORAL022512-003Nov 20, 2015RXNo7,866,474Aug 31, 2027Y
Boehringer Ingelheim
dabigatran etexilate mesylate
CAPSULE;ORAL022512-002Oct 19, 2010RXYes7,866,474Aug 31, 2027Y
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 7,866,474

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany10 2004 062 864Dec 21, 2004

International Patent Family for Patent: 7,866,474

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
New Zealand556336<subscribe>
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.